Comparison of ethanol plasma protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations

被引:55
作者
Ma, JG [1 ]
Stoter, G [1 ]
Verweij, J [1 ]
Schellens, JHM [1 ]
机构
[1] ROTTERDAM CANC INST, DANIEL DEN HOED KLIN, UNIV HOSP, DEPT MED ONCOL, 3008 AE ROTTERDAM, NETHERLANDS
关键词
cisplatin; carboplatin; unbound platinum;
D O I
10.1007/s002800050501
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sample preparation for the measurement of non-protein-bound platinum was evaluated by precipitation of plasma proteins with cold ethanol. The method was compared with the routinely used plasma ultrafiltration and with trichloroacetic acid (TCA) protein precipitation. After incubation of human plasma samples with cisplatin or carboplatin, unbound platinum concentrations were determined applying Amicon Diaflo ultrafiltration membranes and Millipore ultra-free-MC filters. For protein precipitation, 1 ml of cold (-20 degrees C) pure ethanol was added to 0.5 ml of human plasma and the supernatant was collected after 2 h, or 0.5 ml of cold 20% TCA was added to 0.5 mi of plasma. Platinum was analyzed by atomic absorption spectrophotometry (AAS). There was no significant difference between the ethanol and ultrafiltration methods in the unbound platinum concentration. The protein content in the supernatant (1.00 +/- 0.20%) was slightly higher than that in the Amicon (0.58 +/- 0.05%) and Millipore (0.55 +/- 0.04%) ultrafiltrates. On average, the TCA and ethanol method seemed to be equally appropriate. The ethanol precipitation method is concluded to be simple, convenient, and reproducible and has negligible costs.
引用
收藏
页码:391 / 394
页数:4
相关论文
共 26 条
[1]   CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].
CALVERT, AH ;
NEWELL, DR ;
GUMBRELL, LA ;
OREILLY, S ;
BURNELL, M ;
BOXALL, FE ;
SIDDIK, ZH ;
JUDSON, IR ;
GORE, ME ;
WILTSHAW, E .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756
[2]   THE OPTIMIZATION OF CARBOPLATIN DOSE IN CARBOPLATIN, ETOPOSIDE AND BLEOMYCIN COMBINATION CHEMOTHERAPY FOR GOOD PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS [J].
CHILDS, WJ ;
NICHOLLS, EJ ;
HORWICH, A .
ANNALS OF ONCOLOGY, 1992, 3 (04) :291-296
[3]   PREPARATION AND METABOLISM OF A CISPLATIN-SERUM PROTEIN COMPLEX [J].
COLE, WC ;
WOLF, W .
CHEMICO-BIOLOGICAL INTERACTIONS, 1980, 30 (02) :223-235
[4]  
COLE WC, 1981, CHEM-BIOL INTERACT, V31, P341
[5]  
Egorin M J, 1992, Semin Oncol, V19, P132
[6]   EFFECTS OF STORAGE ON THE BINDING OF CARBOPLATIN TO PLASMA-PROTEINS [J].
ERKMEN, K ;
EGORIN, MJ ;
REYNO, LM ;
MORGAN, R ;
DOROSHOW, JH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (03) :254-256
[7]  
FOURNIER C, 1988, CANCER CHEMOTH PHARM, V21, P75
[8]   EXTRACORPOREAL HEMOFILTRATION - A MODEL FOR DECREASING SYSTEMIC DRUG EXPOSURE WITH INTRAARTERIAL CHEMOTHERAPY [J].
GRAHAM, RA ;
SIDDIK, ZH ;
HOHN, DC .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (03) :210-214
[9]   CLINICAL KINETICS OF INTACT CISPLATIN AND SOME RELATED SPECIES [J].
HIMMELSTEIN, KJ ;
PATTON, TF ;
BELT, RJ ;
TAYLOR, S ;
REPTA, AJ ;
STERNSON, LA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :658-664
[10]  
HOLLER E, 1993, METAL COMPLEXES CANC, P40